NCT05786924 2026-04-21Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive MalignanciesServierPhase 1/2 Recruiting554 enrolled
NCT07094204 2026-04-15A Study to Find a Suitable Dose of ASP5834 in Adults With Solid TumorsAstellas Pharma IncPhase 1 Recruiting364 enrolled